Now showing items 1-1 of 1

    • Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study. 

      Schrijver, LH; Olsson, H; Phillips, K-A; Terry, MB; Goldgar, DE; Kast, K; Engel, C; Mooij, TM; Adlard, J; Barrowdale, D; Davidson, R; Eeles, R; Ellis, S; Evans, DG; Frost, D; Izatt, L; Porteous, ME; Side, LE; Walker, L; Berthet, P; Bonadona, V; Leroux, D; Mouret-Fourme, E; Venat-Bouvet, L; Buys, SS; Southey, MC; John, EM; Chung, WK; Daly, MB; Bane, A; van Asperen, CJ; Gómez Garcia, EB; Mourits, MJE; van Os, TAM; Roos-Blom, M-J; Friedlander, ML; McLachlan, S-A; Singer, CF; Tan, YY; Foretova, L; Navratilova, M; Gerdes, A-M; Caldes, T; Simard, J; Olah, E; Jakubowska, A; Arver, B; Osorio, A; Noguès, C; Andrieu, N; Easton, DF; van Leeuwen, FE; Hopper, JL; Milne, RL; Antoniou, AC; Rookus, MA; EMBRACE, GENEPSO, BCFR, HEBON, kConFab, and IBCCS (2018-04)
      Background For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use and breast cancer (BC) risk is still unclear.Methods Breast camcer risk associations were estimated from ...